Bloomberg Law
May 4, 2020, 9:40 AM

Generic Drug Decisions Stall as Virus Forces Patent Court Delays

Valerie Bauman
Valerie Bauman

Patients with cancer, kidney disease, and other ailments could pay higher drug prices for months longer than they otherwise would thanks to court delays caused by the coronavirus outbreak.

At least six patent infringement lawsuits over brand-name drugs are at risk of surpassing—or are already set to exceed—Food and Drug Administration timelines for approving generic versions, according to a Bloomberg Law analysis of court dockets. Depending on how long the pandemic goes on, that list could grow.

“Given the extraordinary circumstances we are in, it’s very likely there will be disruptions that will create a risk of delayed entry” of ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.